1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nitinol-based Interventional Device Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nitinol-based Interventional Device by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nitinol-based Interventional Device by Country/Region, 2018, 2022 & 2029
2.2 Nitinol-based Interventional Device Segment by Type
2.2.1 Stents
2.2.2 Guidewires
2.2.3 Others
2.3 Nitinol-based Interventional Device Sales by Type
2.3.1 Global Nitinol-based Interventional Device Sales Market Share by Type (2018-2023)
2.3.2 Global Nitinol-based Interventional Device Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nitinol-based Interventional Device Sale Price by Type (2018-2023)
2.4 Nitinol-based Interventional Device Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Nitinol-based Interventional Device Sales by Application
2.5.1 Global Nitinol-based Interventional Device Sale Market Share by Application (2018-2023)
2.5.2 Global Nitinol-based Interventional Device Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nitinol-based Interventional Device Sale Price by Application (2018-2023)
3 Global Nitinol-based Interventional Device by Company
3.1 Global Nitinol-based Interventional Device Breakdown Data by Company
3.1.1 Global Nitinol-based Interventional Device Annual Sales by Company (2018-2023)
3.1.2 Global Nitinol-based Interventional Device Sales Market Share by Company (2018-2023)
3.2 Global Nitinol-based Interventional Device Annual Revenue by Company (2018-2023)
3.2.1 Global Nitinol-based Interventional Device Revenue by Company (2018-2023)
3.2.2 Global Nitinol-based Interventional Device Revenue Market Share by Company (2018-2023)
3.3 Global Nitinol-based Interventional Device Sale Price by Company
3.4 Key Manufacturers Nitinol-based Interventional Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nitinol-based Interventional Device Product Location Distribution
3.4.2 Players Nitinol-based Interventional Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nitinol-based Interventional Device by Geographic Region
4.1 World Historic Nitinol-based Interventional Device Market Size by Geographic Region (2018-2023)
4.1.1 Global Nitinol-based Interventional Device Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nitinol-based Interventional Device Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nitinol-based Interventional Device Market Size by Country/Region (2018-2023)
4.2.1 Global Nitinol-based Interventional Device Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nitinol-based Interventional Device Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nitinol-based Interventional Device Sales Growth
4.4 APAC Nitinol-based Interventional Device Sales Growth
4.5 Europe Nitinol-based Interventional Device Sales Growth
4.6 Middle East & Africa Nitinol-based Interventional Device Sales Growth
5 Americas
5.1 Americas Nitinol-based Interventional Device Sales by Country
5.1.1 Americas Nitinol-based Interventional Device Sales by Country (2018-2023)
5.1.2 Americas Nitinol-based Interventional Device Revenue by Country (2018-2023)
5.2 Americas Nitinol-based Interventional Device Sales by Type
5.3 Americas Nitinol-based Interventional Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nitinol-based Interventional Device Sales by Region
6.1.1 APAC Nitinol-based Interventional Device Sales by Region (2018-2023)
6.1.2 APAC Nitinol-based Interventional Device Revenue by Region (2018-2023)
6.2 APAC Nitinol-based Interventional Device Sales by Type
6.3 APAC Nitinol-based Interventional Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nitinol-based Interventional Device by Country
7.1.1 Europe Nitinol-based Interventional Device Sales by Country (2018-2023)
7.1.2 Europe Nitinol-based Interventional Device Revenue by Country (2018-2023)
7.2 Europe Nitinol-based Interventional Device Sales by Type
7.3 Europe Nitinol-based Interventional Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nitinol-based Interventional Device by Country
8.1.1 Middle East & Africa Nitinol-based Interventional Device Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nitinol-based Interventional Device Revenue by Country (2018-2023)
8.2 Middle East & Africa Nitinol-based Interventional Device Sales by Type
8.3 Middle East & Africa Nitinol-based Interventional Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nitinol-based Interventional Device
10.3 Manufacturing Process Analysis of Nitinol-based Interventional Device
10.4 Industry Chain Structure of Nitinol-based Interventional Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nitinol-based Interventional Device Distributors
11.3 Nitinol-based Interventional Device Customer
12 World Forecast Review for Nitinol-based Interventional Device by Geographic Region
12.1 Global Nitinol-based Interventional Device Market Size Forecast by Region
12.1.1 Global Nitinol-based Interventional Device Forecast by Region (2024-2029)
12.1.2 Global Nitinol-based Interventional Device Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nitinol-based Interventional Device Forecast by Type
12.7 Global Nitinol-based Interventional Device Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Nitinol-based Interventional Device Product Portfolios and Specifications
13.1.3 Abbott Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Edwards Lifesciences
13.2.1 Edwards Lifesciences Company Information
13.2.2 Edwards Lifesciences Nitinol-based Interventional Device Product Portfolios and Specifications
13.2.3 Edwards Lifesciences Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Edwards Lifesciences Main Business Overview
13.2.5 Edwards Lifesciences Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Nitinol-based Interventional Device Product Portfolios and Specifications
13.3.3 Medtronic Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Boston Scientific
13.4.1 Boston Scientific Company Information
13.4.2 Boston Scientific Nitinol-based Interventional Device Product Portfolios and Specifications
13.4.3 Boston Scientific Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boston Scientific Main Business Overview
13.4.5 Boston Scientific Latest Developments
13.5 TERUMO
13.5.1 TERUMO Company Information
13.5.2 TERUMO Nitinol-based Interventional Device Product Portfolios and Specifications
13.5.3 TERUMO Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 TERUMO Main Business Overview
13.5.5 TERUMO Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD Nitinol-based Interventional Device Product Portfolios and Specifications
13.6.3 BD Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 Stryker
13.7.1 Stryker Company Information
13.7.2 Stryker Nitinol-based Interventional Device Product Portfolios and Specifications
13.7.3 Stryker Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Stryker Main Business Overview
13.7.5 Stryker Latest Developments
13.8 Cook Medical
13.8.1 Cook Medical Company Information
13.8.2 Cook Medical Nitinol-based Interventional Device Product Portfolios and Specifications
13.8.3 Cook Medical Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Cook Medical Main Business Overview
13.8.5 Cook Medical Latest Developments
13.9 Cordis
13.9.1 Cordis Company Information
13.9.2 Cordis Nitinol-based Interventional Device Product Portfolios and Specifications
13.9.3 Cordis Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Cordis Main Business Overview
13.9.5 Cordis Latest Developments
13.10 B. Braun
13.10.1 B. Braun Company Information
13.10.2 B. Braun Nitinol-based Interventional Device Product Portfolios and Specifications
13.10.3 B. Braun Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 B. Braun Main Business Overview
13.10.5 B. Braun Latest Developments
13.11 Biotronik
13.11.1 Biotronik Company Information
13.11.2 Biotronik Nitinol-based Interventional Device Product Portfolios and Specifications
13.11.3 Biotronik Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Biotronik Main Business Overview
13.11.5 Biotronik Latest Developments
13.12 MicroPort
13.12.1 MicroPort Company Information
13.12.2 MicroPort Nitinol-based Interventional Device Product Portfolios and Specifications
13.12.3 MicroPort Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 MicroPort Main Business Overview
13.12.5 MicroPort Latest Developments
13.13 JOTEC
13.13.1 JOTEC Company Information
13.13.2 JOTEC Nitinol-based Interventional Device Product Portfolios and Specifications
13.13.3 JOTEC Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 JOTEC Main Business Overview
13.13.5 JOTEC Latest Developments
13.14 Acandis
13.14.1 Acandis Company Information
13.14.2 Acandis Nitinol-based Interventional Device Product Portfolios and Specifications
13.14.3 Acandis Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Acandis Main Business Overview
13.14.5 Acandis Latest Developments
13.15 ELLA-CS
13.15.1 ELLA-CS Company Information
13.15.2 ELLA-CS Nitinol-based Interventional Device Product Portfolios and Specifications
13.15.3 ELLA-CS Nitinol-based Interventional Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 ELLA-CS Main Business Overview
13.15.5 ELLA-CS Latest Developments
14 Research Findings and Conclusion
Table 1. Nitinol-based Interventional Device Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nitinol-based Interventional Device Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Stents
Table 4. Major Players of Guidewires
Table 5. Major Players of Others
Table 6. Global Nitinol-based Interventional Device Sales by Type (2018-2023) & (Units)
Table 7. Global Nitinol-based Interventional Device Sales Market Share by Type (2018-2023)
Table 8. Global Nitinol-based Interventional Device Revenue by Type (2018-2023) & ($ million)
Table 9. Global Nitinol-based Interventional Device Revenue Market Share by Type (2018-2023)
Table 10. Global Nitinol-based Interventional Device Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Nitinol-based Interventional Device Sales by Application (2018-2023) & (Units)
Table 12. Global Nitinol-based Interventional Device Sales Market Share by Application (2018-2023)
Table 13. Global Nitinol-based Interventional Device Revenue by Application (2018-2023)
Table 14. Global Nitinol-based Interventional Device Revenue Market Share by Application (2018-2023)
Table 15. Global Nitinol-based Interventional Device Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Nitinol-based Interventional Device Sales by Company (2018-2023) & (Units)
Table 17. Global Nitinol-based Interventional Device Sales Market Share by Company (2018-2023)
Table 18. Global Nitinol-based Interventional Device Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Nitinol-based Interventional Device Revenue Market Share by Company (2018-2023)
Table 20. Global Nitinol-based Interventional Device Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Nitinol-based Interventional Device Producing Area Distribution and Sales Area
Table 22. Players Nitinol-based Interventional Device Products Offered
Table 23. Nitinol-based Interventional Device Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Nitinol-based Interventional Device Sales by Geographic Region (2018-2023) & (Units)
Table 27. Global Nitinol-based Interventional Device Sales Market Share Geographic Region (2018-2023)
Table 28. Global Nitinol-based Interventional Device Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Nitinol-based Interventional Device Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Nitinol-based Interventional Device Sales by Country/Region (2018-2023) & (Units)
Table 31. Global Nitinol-based Interventional Device Sales Market Share by Country/Region (2018-2023)
Table 32. Global Nitinol-based Interventional Device Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Nitinol-based Interventional Device Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Nitinol-based Interventional Device Sales by Country (2018-2023) & (Units)
Table 35. Americas Nitinol-based Interventional Device Sales Market Share by Country (2018-2023)
Table 36. Americas Nitinol-based Interventional Device Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Nitinol-based Interventional Device Revenue Market Share by Country (2018-2023)
Table 38. Americas Nitinol-based Interventional Device Sales by Type (2018-2023) & (Units)
Table 39. Americas Nitinol-based Interventional Device Sales by Application (2018-2023) & (Units)
Table 40. APAC Nitinol-based Interventional Device Sales by Region (2018-2023) & (Units)
Table 41. APAC Nitinol-based Interventional Device Sales Market Share by Region (2018-2023)
Table 42. APAC Nitinol-based Interventional Device Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Nitinol-based Interventional Device Revenue Market Share by Region (2018-2023)
Table 44. APAC Nitinol-based Interventional Device Sales by Type (2018-2023) & (Units)
Table 45. APAC Nitinol-based Interventional Device Sales by Application (2018-2023) & (Units)
Table 46. Europe Nitinol-based Interventional Device Sales by Country (2018-2023) & (Units)
Table 47. Europe Nitinol-based Interventional Device Sales Market Share by Country (2018-2023)
Table 48. Europe Nitinol-based Interventional Device Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Nitinol-based Interventional Device Revenue Market Share by Country (2018-2023)
Table 50. Europe Nitinol-based Interventional Device Sales by Type (2018-2023) & (Units)
Table 51. Europe Nitinol-based Interventional Device Sales by Application (2018-2023) & (Units)
Table 52. Middle East & Africa Nitinol-based Interventional Device Sales by Country (2018-2023) & (Units)
Table 53. Middle East & Africa Nitinol-based Interventional Device Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Nitinol-based Interventional Device Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Nitinol-based Interventional Device Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Nitinol-based Interventional Device Sales by Type (2018-2023) & (Units)
Table 57. Middle East & Africa Nitinol-based Interventional Device Sales by Application (2018-2023) & (Units)
Table 58. Key Market Drivers & Growth Opportunities of Nitinol-based Interventional Device
Table 59. Key Market Challenges & Risks of Nitinol-based Interventional Device
Table 60. Key Industry Trends of Nitinol-based Interventional Device
Table 61. Nitinol-based Interventional Device Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Nitinol-based Interventional Device Distributors List
Table 64. Nitinol-based Interventional Device Customer List
Table 65. Global Nitinol-based Interventional Device Sales Forecast by Region (2024-2029) & (Units)
Table 66. Global Nitinol-based Interventional Device Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Nitinol-based Interventional Device Sales Forecast by Country (2024-2029) & (Units)
Table 68. Americas Nitinol-based Interventional Device Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Nitinol-based Interventional Device Sales Forecast by Region (2024-2029) & (Units)
Table 70. APAC Nitinol-based Interventional Device Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Nitinol-based Interventional Device Sales Forecast by Country (2024-2029) & (Units)
Table 72. Europe Nitinol-based Interventional Device Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Nitinol-based Interventional Device Sales Forecast by Country (2024-2029) & (Units)
Table 74. Middle East & Africa Nitinol-based Interventional Device Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Nitinol-based Interventional Device Sales Forecast by Type (2024-2029) & (Units)
Table 76. Global Nitinol-based Interventional Device Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Nitinol-based Interventional Device Sales Forecast by Application (2024-2029) & (Units)
Table 78. Global Nitinol-based Interventional Device Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Abbott Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 80. Abbott Nitinol-based Interventional Device Product Portfolios and Specifications
Table 81. Abbott Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Abbott Main Business
Table 83. Abbott Latest Developments
Table 84. Edwards Lifesciences Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 85. Edwards Lifesciences Nitinol-based Interventional Device Product Portfolios and Specifications
Table 86. Edwards Lifesciences Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Edwards Lifesciences Main Business
Table 88. Edwards Lifesciences Latest Developments
Table 89. Medtronic Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 90. Medtronic Nitinol-based Interventional Device Product Portfolios and Specifications
Table 91. Medtronic Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Medtronic Main Business
Table 93. Medtronic Latest Developments
Table 94. Boston Scientific Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 95. Boston Scientific Nitinol-based Interventional Device Product Portfolios and Specifications
Table 96. Boston Scientific Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Boston Scientific Main Business
Table 98. Boston Scientific Latest Developments
Table 99. TERUMO Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 100. TERUMO Nitinol-based Interventional Device Product Portfolios and Specifications
Table 101. TERUMO Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. TERUMO Main Business
Table 103. TERUMO Latest Developments
Table 104. BD Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 105. BD Nitinol-based Interventional Device Product Portfolios and Specifications
Table 106. BD Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. BD Main Business
Table 108. BD Latest Developments
Table 109. Stryker Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 110. Stryker Nitinol-based Interventional Device Product Portfolios and Specifications
Table 111. Stryker Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Stryker Main Business
Table 113. Stryker Latest Developments
Table 114. Cook Medical Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 115. Cook Medical Nitinol-based Interventional Device Product Portfolios and Specifications
Table 116. Cook Medical Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Cook Medical Main Business
Table 118. Cook Medical Latest Developments
Table 119. Cordis Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 120. Cordis Nitinol-based Interventional Device Product Portfolios and Specifications
Table 121. Cordis Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Cordis Main Business
Table 123. Cordis Latest Developments
Table 124. B. Braun Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 125. B. Braun Nitinol-based Interventional Device Product Portfolios and Specifications
Table 126. B. Braun Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. B. Braun Main Business
Table 128. B. Braun Latest Developments
Table 129. Biotronik Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 130. Biotronik Nitinol-based Interventional Device Product Portfolios and Specifications
Table 131. Biotronik Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Biotronik Main Business
Table 133. Biotronik Latest Developments
Table 134. MicroPort Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 135. MicroPort Nitinol-based Interventional Device Product Portfolios and Specifications
Table 136. MicroPort Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. MicroPort Main Business
Table 138. MicroPort Latest Developments
Table 139. JOTEC Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 140. JOTEC Nitinol-based Interventional Device Product Portfolios and Specifications
Table 141. JOTEC Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. JOTEC Main Business
Table 143. JOTEC Latest Developments
Table 144. Acandis Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 145. Acandis Nitinol-based Interventional Device Product Portfolios and Specifications
Table 146. Acandis Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Acandis Main Business
Table 148. Acandis Latest Developments
Table 149. ELLA-CS Basic Information, Nitinol-based Interventional Device Manufacturing Base, Sales Area and Its Competitors
Table 150. ELLA-CS Nitinol-based Interventional Device Product Portfolios and Specifications
Table 151. ELLA-CS Nitinol-based Interventional Device Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. ELLA-CS Main Business
Table 153. ELLA-CS Latest Developments
List of Figures
Figure 1. Picture of Nitinol-based Interventional Device
Figure 2. Nitinol-based Interventional Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nitinol-based Interventional Device Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Nitinol-based Interventional Device Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nitinol-based Interventional Device Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Stents
Figure 10. Product Picture of Guidewires
Figure 11. Product Picture of Others
Figure 12. Global Nitinol-based Interventional Device Sales Market Share by Type in 2022
Figure 13. Global Nitinol-based Interventional Device Revenue Market Share by Type (2018-2023)
Figure 14. Nitinol-based Interventional Device Consumed in Hospital
Figure 15. Global Nitinol-based Interventional Device Market: Hospital (2018-2023) & (Units)
Figure 16. Nitinol-based Interventional Device Consumed in Clinic
Figure 17. Global Nitinol-based Interventional Device Market: Clinic (2018-2023) & (Units)
Figure 18. Nitinol-based Interventional Device Consumed in Others
Figure 19. Global Nitinol-based Interventional Device Market: Others (2018-2023) & (Units)
Figure 20. Global Nitinol-based Interventional Device Sales Market Share by Application (2022)
Figure 21. Global Nitinol-based Interventional Device Revenue Market Share by Application in 2022
Figure 22. Nitinol-based Interventional Device Sales Market by Company in 2022 (Units)
Figure 23. Global Nitinol-based Interventional Device Sales Market Share by Company in 2022
Figure 24. Nitinol-based Interventional Device Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Nitinol-based Interventional Device Revenue Market Share by Company in 2022
Figure 26. Global Nitinol-based Interventional Device Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Nitinol-based Interventional Device Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Nitinol-based Interventional Device Sales 2018-2023 (Units)
Figure 29. Americas Nitinol-based Interventional Device Revenue 2018-2023 ($ Millions)
Figure 30. APAC Nitinol-based Interventional Device Sales 2018-2023 (Units)
Figure 31. APAC Nitinol-based Interventional Device Revenue 2018-2023 ($ Millions)
Figure 32. Europe Nitinol-based Interventional Device Sales 2018-2023 (Units)
Figure 33. Europe Nitinol-based Interventional Device Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Nitinol-based Interventional Device Sales 2018-2023 (Units)
Figure 35. Middle East & Africa Nitinol-based Interventional Device Revenue 2018-2023 ($ Millions)
Figure 36. Americas Nitinol-based Interventional Device Sales Market Share by Country in 2022
Figure 37. Americas Nitinol-based Interventional Device Revenue Market Share by Country in 2022
Figure 38. Americas Nitinol-based Interventional Device Sales Market Share by Type (2018-2023)
Figure 39. Americas Nitinol-based Interventional Device Sales Market Share by Application (2018-2023)
Figure 40. United States Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Nitinol-based Interventional Device Sales Market Share by Region in 2022
Figure 45. APAC Nitinol-based Interventional Device Revenue Market Share by Regions in 2022
Figure 46. APAC Nitinol-based Interventional Device Sales Market Share by Type (2018-2023)
Figure 47. APAC Nitinol-based Interventional Device Sales Market Share by Application (2018-2023)
Figure 48. China Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Nitinol-based Interventional Device Sales Market Share by Country in 2022
Figure 56. Europe Nitinol-based Interventional Device Revenue Market Share by Country in 2022
Figure 57. Europe Nitinol-based Interventional Device Sales Market Share by Type (2018-2023)
Figure 58. Europe Nitinol-based Interventional Device Sales Market Share by Application (2018-2023)
Figure 59. Germany Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Nitinol-based Interventional Device Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Nitinol-based Interventional Device Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Nitinol-based Interventional Device Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Nitinol-based Interventional Device Sales Market Share by Application (2018-2023)
Figure 68. Egypt Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Nitinol-based Interventional Device Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Nitinol-based Interventional Device in 2022
Figure 74. Manufacturing Process Analysis of Nitinol-based Interventional Device
Figure 75. Industry Chain Structure of Nitinol-based Interventional Device
Figure 76. Channels of Distribution
Figure 77. Global Nitinol-based Interventional Device Sales Market Forecast by Region (2024-2029)
Figure 78. Global Nitinol-based Interventional Device Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Nitinol-based Interventional Device Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Nitinol-based Interventional Device Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Nitinol-based Interventional Device Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Nitinol-based Interventional Device Revenue Market Share Forecast by Application (2024-2029)
※参考情報 ニチノール製介入装置は、医療分野において重要な役割を果たしているデバイスであり、特に血管や腫瘍などの介入に使用されることが多いです。このデバイスは、ニチノールという特殊な合金素材から作られており、その特性が要求される医療ニーズに応えるために特化されています。 ニチノールは、ニッケルとチタンの合金であり、特異な形状記憶効果と超弾性特性を持つことが最大の特徴です。形状記憶効果とは、特定の温度条件下で元の形状に戻る性質を指します。この特性により、ニチノール製のデバイスは体内に挿入される際に、コンパクトな姿勢に折りたたまれ、体温に達すると元の形状に戻ります。この機能があるため、手術中の取り扱いが容易であり、患者に対する侵襲を最小限に抑えることが可能です。 また、超弾性特性もニチノールの重要な特徴です。この特性により、デバイスは大きな変形を受けた場合でも元の形に戻ることができ、また、力を加えた際に比較的柔軟に動作することが可能です。このような性質により、特に血管内デバイスなどの用途において、慎重な配置や、血管の形状への適応が求められる場面での使用が推奨されます。 ニチノール製介入装置には、さまざまな種類が存在します。代表的なものには、ステント、カテーテル、トロカール、バルーンデバイスなどがあり、それぞれ異なる目的や用途を持っています。ステントは、狭窄した血管を拡張し、再狭窄を防ぐために使用されるデバイスであり、心臓病や脳卒中の治療に多く用いられています。カテーテルは、体内に薬剤を投与したり、診断のために体液を採取したりするために使用されます。また、トロカールは、外科手術の際に体内にアクセスするための器具として用いられ、ニチノールの特性を利用した設計が多く見られます。バルーンデバイスは、特に狭窄部分を一時的に拡張するために使用され、血管内治療において重要な役割を担っています。 これらのデバイスの用途は非常に広範囲にわたり、心血管疾患、消化器系疾患、泌尿器科疾患、さらには腫瘍治療など、さまざまな医療分野で利用されています。ニチノール製デバイスは、特に血管内治療の分野での発展を推進してきた歴史があり、今後も新しい応用が期待されています。 関連技術としては、加工技術や、コーティング技術、画像診断技術が挙げられます。ニチノールの加工には、高度な熱処理技術が必要であり、精密な形状を製造することが求められます。さらに、デバイス表面には生体適合性を向上させるためのコーティングが施されることが多く、この技術も非常に重要です。最新の画像診断技術との統合も重要な要素であり、使用する医療機器の正確な位置情報を提供することで、手術の成功率を高めることに寄与しています。 ニチノール製介入装置の利点として、患者への負担が少なく、回復時間を短縮することが挙げられます。従来の外科手術に比べて、切開のサイズが小さく、手術後の痛みや出血が少なく、入院期間が短くなる傾向があります。このような特性は、医療提供者にとっても大きなメリットであり、患者満足度の向上につながっています。 最近の研究では、より複雑な構造を持つデバイスや、より効率的な治療法が開発されています。ニチノールの特性を活かした新しい機器の開発が多数行われており、臨床現場での評価が進められています。これにより、患者にとっての選択肢が広がっていることは間違いありません。 さらに、ニチノール製介入装置は、合材やデバイスの設計と製造においても非常に多様なアプローチが見られます。この多様性は、医療分野におけるニーズの多様化に応じたものであり、各種の病状に適応できるデバイスの開発を可能にしています。たとえば、近年では、ニチノールを使用した自己拡張型ステントに加え、薬物を放出する機能を持つデバイスも増えており、治療効果の向上が期待されています。 総じて、ニチノール製介入装置は、医療技術の進展における革新を象徴する存在であり、形状記憶特性や超弾性特性を活かしながら、さまざまな医療の場面で有用なソリューションを提供しています。今後もこの分野での研究や開発は進展し、より多くの患者に対して効果的な治療を提供できることが期待されます。ニチノール製介入装置は、今後の医療の在り方を大きく変える可能性を秘めており、継続的な技術革新が注目される領域です。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer